Picker International is preparing production shipments of NeuroFlow,a xenon-gas delivery system that is designed to enable imagingof blood perfusion in the brain. The device received 510(k) clearancelast month and is used with Picker's Prism 3000XP
Picker International is preparing production shipments of NeuroFlow,a xenon-gas delivery system that is designed to enable imagingof blood perfusion in the brain. The device received 510(k) clearancelast month and is used with Picker's Prism 3000XP triple-headgamma camera.
NeuroFlow is an alternative to conventional SPECT radiopharmaceuticalsand consists of a xenon gas that is inhaled by the patient, accordingto Scott Horowitz, marketing communications specialist for theCleveland vendor. NeuroFlow can provide quantitative measurementsof true regional cerebral blood flow, Horowitz said.
Picker will feature NeuroFlow at the upcoming Society of NuclearMedicine meeting in Denver. It will be offered as an option onPrism 3000XP cameras, Horowitz said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.